Topotecan Hydrochloride (Bedford Laboratories)
Welcome to the PulseAid listing for the Topotecan Hydrochloride drug offered from Bedford Laboratories. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bedford Laboratories |
| NON-PROPRIETARY NAME: | Topotecan Hydrochloride |
| SUBSTANCE NAME: | TOPOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-04-18 |
| END MARKETING DATE: | 0000-00-00 |
Topotecan Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Topotecan Hydrochloride from Bedford Laboratories |
| LABELER NAME: | Bedford Laboratories |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(mg/4mL) |
| START MARKETING DATE: | 2011-04-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55390-370_57820857-4427-9067-a130-4e1a6ca3e637 |
| PRODUCT NDC: | 55390-370 |
| APPLICATION NUMBER: | ANDA201191 |
Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
